Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

38.89
+1.163.07%
Post-market: 39.000.1100+0.28%19:55 EDT
Volume:1.75M
Turnover:68.13M
Market Cap:5.23B
PE:-11.17
High:39.37
Open:37.73
Low:37.73
Close:37.73
52wk High:49.70
52wk Low:8.77
Shares:134.37M
Float Shares:131.11M
Volume Ratio:1.28
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4823
EPS(LYR):-2.0600
ROE:-64.09%
ROA:-20.64%
PB:5.69
PE(LYR):-18.88

Loading ...

Definium Therapeutics Issues Equity Inducement Grants to New Hires

TIPRANKS
·
Aug 07

Definium Therapeutics Launches GAD Education Platform Wired for Worry

TIPRANKS
·
Aug 07

Definium Therapeutics Inc Expected to Post a Loss of 55 Cents a Share - Earnings Preview

Reuters
·
Aug 05

Definium Therapeutics Issues Inducement Options for 115,600 Shares to Six New Hires

Reuters
·
Aug 04

Press Release: Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026

Dow Jones
·
Jul 31

Definium Therapeutics to Webcast Q2 Financial Results Update

Reuters
·
Jul 31

Definium Therapeutics, Inc. options imply 11.0% move in share price post-earnings

TIPRANKS
·
Jul 31

Definium Therapeutics Initiated at Overweight by Wells Fargo

Dow Jones
·
Jul 27

Definium Therapeutics initiated with an Overweight at Wells Fargo

TIPRANKS
·
Jul 27

Definium Therapeutics Price Target Raised to $73.00/share from $48.00 by Piper Sandler

Dow Jones
·
Jul 24

Definium Therapeutics price target raised to $73 from $48 at Piper Sandler

TIPRANKS
·
Jul 24

U.S. Research Roundup-deckers Brands, Rollins, United Rentals

Reuters
·
Jul 24

Movement Alert|Definium Therapeutics Rises 5.14% in Regular Trading, Trading at $45.02

Market Focus
·
Jul 22

Definium Therapeutics Issues Options for 30,330 Shares to New Hires Under Inducement Plan

Reuters
·
Jul 21

Movement Alert|Definium Therapeutics Rises 5.5% in Regular Trading, DT120 Phase 3 Data and Sector M&A Fuel Momentum

Market Focus
·
Jul 16

S&P 500 Futures Decline in Premarket Trading; Ermenegildo Zegna, JB Hunt Transport Lead

Dow Jones
·
Jul 16

Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (gad) Patient Impact and Neurobiology

THOMSON REUTERS
·
Jul 16

Movement Alert|Definium Therapeutics Rises 5.1% in Pre-Market Trading, DT120 Phase 3 Data and Capital Raise Continue to Fuel Momentum

Market Focus
·
Jul 16

Movement Alert|Definium Therapeutics Rises 7.03% Overnight, DT120 Phase 3 Data Momentum Continues

Market Focus
·
Jul 16

Movement Alert|Definium Therapeutics Rises 5.04% in After-Hours Trading, Trading at $47.79

Market Focus
·
Jul 16